Literature DB >> 11040023

Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery.

C Gohlke-Bärwolf1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040023      PMCID: PMC1729481          DOI: 10.1136/heart.84.5.567

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  14 in total

1.  AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves.

Authors:  J Acar; B Iung; J P Boissel; M M Samama; P L Michel; J P Teppe; J C Pony; H L Breton; D Thomas; R Isnard; G de Gevigney; E Viguier; A Sfihi; G Hanania; M Ghannem; A Mirode; C Nemoz
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

2.  Correction of excessive anticoagulation with low-dose oral vitamin K1.

Authors:  R T Weibert; D T Le; S R Kayser; S I Rapaport
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

Review 3.  Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology.

Authors:  C Gohlke-Bärwolf; J Acar; C Oakley; E Butchart; D Burckhart; E Bodnar; R Hall; J P Delahaye; D Horstkotte; R Krémer
Journal:  Eur Heart J       Date:  1995-10       Impact factor: 29.983

4.  Low molecular weight heparin after mechanical heart valve replacement.

Authors:  G Montalescot; V Polle; J P Collet; P Leprince; A Bellanger; I Gandjbakhch; D Thomas
Journal:  Circulation       Date:  2000-03-14       Impact factor: 29.690

5.  Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1.

Authors:  H G Shetty; G Backhouse; D P Bentley; P A Routledge
Journal:  Thromb Haemost       Date:  1992-01-23       Impact factor: 5.249

6.  Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.

Authors:  T P Carrel; W Klingenmann; P J Mohacsi; P Berdat; U Althaus
Journal:  J Heart Valve Dis       Date:  1999-07

7.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

8.  A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.

Authors:  A G Turpie; M Gent; A Laupacis; Y Latour; J Gunstensen; F Basile; M Klimek; J Hirsh
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245

Review 9.  Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.

Authors:  S C Cannegieter; F R Rosendaal; E Briët
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

10.  Temporary discontinuation of warfarin therapy: changes in the international normalized ratio.

Authors:  R H White; T McKittrick; R Hutchinson; J Twitchell
Journal:  Ann Intern Med       Date:  1995-01-01       Impact factor: 25.391

View more
  12 in total

1.  Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement.

Authors:  I Müller; M Seyfarth; S Rüdiger; B Wolf; G Pogatsa-Murray; A Schömig; M Gawaz
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

2.  Management of severe heart failure by specialist palliative care.

Authors:  A R Thorns; L M Gibbs; J S Gibbs
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

Review 3.  The medical management of valvar heart disease.

Authors:  N A Boon; P Bloomfield
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

Review 4.  Choice of heart valve prosthesis.

Authors:  Peter Bloomfield
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

Review 5.  Management and follow up of prosthetic heart valves.

Authors:  Christian Seiler
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

Review 6.  Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations.

Authors:  Raymond Roudaut; Karim Serri; Stephane Lafitte
Journal:  Heart       Date:  2007-01       Impact factor: 5.994

Review 7.  Valve disease: Surgery of valve disease: late results and late complications.

Authors:  P Groves
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

8.  [Current recommendations for prevention of thromboembolic events in patients with heart valve prostheses].

Authors:  C Gohlke-Bärwolf
Journal:  Z Kardiol       Date:  2001-12

9.  Fulminant thrombosis of mechanical mitral valve prosthesis.

Authors:  M Zielinska; N F Haegele; C Firschke
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

10.  Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol.

Authors:  I Ferreira; L Dos; P Tornos; I Nicolau; G Permanyer-Miralda; J Soler-Soler
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.